2010
DOI: 10.1016/j.dld.2009.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Cholangiocarcinoma: Update and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
117
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 162 publications
(120 citation statements)
references
References 148 publications
3
117
0
Order By: Relevance
“…7 The carbohydrate antigen CA-19-9 is widely used for diagnosis of CCA, but it lacks specificity, because it is also a marker for pancreatic cancer, gastric cancer, and primary biliary cirrhosis and is elevated in smokers. 11 Carcinoembryonic antigen, a marker for colorectal cancer, is elevated in approximately 30% of CCA patients. 12,13 Some potential biomarkers for CCA are trypsinogen-2, 14 mucin-5AC, and the soluble fragment of cytokeratin 19, although none are currently in clinical use.…”
Section: Resultsmentioning
confidence: 99%
“…7 The carbohydrate antigen CA-19-9 is widely used for diagnosis of CCA, but it lacks specificity, because it is also a marker for pancreatic cancer, gastric cancer, and primary biliary cirrhosis and is elevated in smokers. 11 Carcinoembryonic antigen, a marker for colorectal cancer, is elevated in approximately 30% of CCA patients. 12,13 Some potential biomarkers for CCA are trypsinogen-2, 14 mucin-5AC, and the soluble fragment of cytokeratin 19, although none are currently in clinical use.…”
Section: Resultsmentioning
confidence: 99%
“…It is the second most common primary hepatic malignancy after hepatocellular cancer, contributing to approximately 10-25% of all hepatobiliary malignancies (Blechacz et al, 2008;Sripa et al, 2008;Gatto et al, 2010). The incidence of CC varies enormously by geographic region and demographic diversity, with the highest incidence in Southeast Asia and the lowest in Australia (Shaib et al, 2004;Sripa et al, 2008;Barusrux et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Klatskin tumor, i.e Hilar CC, is typically classified as extrahepatic (Tyson et al, 2011). The clinical distinction between ICC and ECC has become significantly crucial due to their possibly different epidemiological characteristics (Patel., 2006;Gatto et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…2,4,5,7 In contrast, prognosis and survival of patients with intrahepatic cholangiocarcinoma is significantly worse than hepatocellular carcinoma. 5,8,9 Lymph node dissection is routinely performed during resection of intrahepatic cholangiocarcinoma but not hepatocellular carcinoma, as lymph node metastasis is relatively uncommon in the latter. 10,11 Treatment options for unresectable hepatocellular carcinoma include sorafenib and intra-arterial chemoembolization, whereas chemotherapeutic agents such as gemcitabine and fluoropyramidines are not beneficial.…”
mentioning
confidence: 99%